Skip to main content
Weiter zur Homepage der Europäischen Kommission (öffnet in neuem Fenster)
Deutsch de
CORDIS - Forschungsergebnisse der EU
CORDIS

Automated Organoid Screening Platform For Drug Discovery and Precision Medicine

Ziel

The project addresses Challenge 2 of the European Innovation Council Advanced Innovation Challenges Pilot by advancing a disruptive New Approach Methodology (NAM) platform designed to accelerate cancer drug development while reducing reliance on exploratory animal experimentation.
OKOMERA’s Ocentra platform is a compact, automated benchtop system integrating rapid 48-hour three-dimensional organoid generation from minute patient-derived tumor samples with automated microfluidic standardization and AI-driven analytics in a single industrial workflow. Unlike existing organoid platforms relying on manual multiwell expansion and fragmented processes, Ocentra enables standardized, miniaturized, and traceable generation of uniform tumor microtissues. This directly addresses a major barrier to NAM adoption: the lack of reproducible and transferable systems compatible with pharmaceutical R&D environments.
The prototype has been validated in-house using multiple patient-derived tumor models, demonstrating reliable automated 3D culture formation and reproducible compound exposure suitable for target validation and quantitative dose-response profiling.
The EIC AIC Stage 1 project will conduct the first independent validation of the prototype in an external pharmaceutical research laboratory to assess robustness, reproducibility and operational feasibility outside the developer’s facilities. In parallel, the project will implement a robust data governance framework ensuring traceability and regulatory-aligned handling of patient-derived biological materials, and define a Stage 2 transition strategy including a regulatory and commercial adoption roadmap and formalized commitments from industrial and clinical partners to support continued validation and pilot activities.

Wissenschaftliches Gebiet (EuroSciVoc)

Schlüsselbegriffe

Programm/Programme

Thema/Themen

Finanzierungsplan

HORIZON-EIC - HORIZON EIC Grants

Alle im Rahmen dieses Finanzierungsinstruments finanzierten Projekte anzeigen

Aufforderung zur Vorschlagseinreichung

(öffnet in neuem Fenster) HORIZON-EIC-2026-AIC

Alle im Rahmen dieser Aufforderung zur Einreichung von Vorschlägen finanzierten Projekte anzeigen

Koordinator

OKOMERA
Netto-EU-Beitrag
€ 300 000,00
Adresse
9bis rue d'Alembert
75014 Paris
Frankreich
KMU
Ja
Region
Ile-de-France Ile-de-France Paris
Aktivitätstyp
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Gesamtkosten
Keine Daten